Literature DB >> 4045529

Exploratory data analysis and the use of the hazard function for interpreting survival data: an investigator's primer.

R J Simes, M Zelen.   

Abstract

This report discusses how one can use the hazard function to gain important insights on the patterns of failure in clinical studies when the principal endpoint is a time metric. These new insights may help gain increased understanding into the pathogenesis of a chronic disease and how it is affected by treatment intervention. The qualitative behavior of the hazard function can reveal whether mortality is increasing, decreasing, or is constant over time. Simple graphic plots are all that is necessary to show characteristic failure patterns. These informal procedures are in the spirit of carrying out exploratory analyses on the data. This report discusses the organization of clinical data using a "branch and leaf" plot, outlines the calculation of the hazard function and life table, and uses examples from lung cancer and uveal melanoma to illustrate calculations and ways of interpreting hazard functions.

Entities:  

Mesh:

Year:  1985        PMID: 4045529     DOI: 10.1200/JCO.1985.3.10.1418

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  19 in total

1.  Using clinical trial data to tailor adjuvant treatments for individual patients.

Authors:  Meredith M Regan; Richard D Gelber
Journal:  Breast       Date:  2007-08-23       Impact factor: 4.380

2.  Parametric modeling of localized melanoma prognosis and outcome.

Authors:  Shouluan Ding; Seng-Jaw Soong; Hui-Yi Lin; Renee Desmond; Charles M Balch
Journal:  J Biopharm Stat       Date:  2009-07       Impact factor: 1.051

3.  Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy.

Authors:  R Demicheli; A Abbattista; R Miceli; P Valagussa; G Bonadonna
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival.

Authors:  Hideki Ujiie; Kyuichi Kadota; Jamie E Chaft; Daniel Buitrago; Camelia S Sima; Ming-Ching Lee; James Huang; William D Travis; Nabil P Rizk; Charles M Rudin; David R Jones; Prasad S Adusumilli
Journal:  J Clin Oncol       Date:  2015-08-10       Impact factor: 44.544

5.  Cell kinetics: an independent prognostic variable in stage II melanoma of the skin.

Authors:  A Costa; R Silvestrini; G Mezzanotte; M Vaglini; E Grignolio; C Clemente; N Cascinelli
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

6.  Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour.

Authors:  Romano Demicheli; Gianni Bonadonna; William J M Hrushesky; Michael W Retsky; Pinuccia Valagussa
Journal:  Breast Cancer Res       Date:  2004-10-11       Impact factor: 6.466

7.  Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients.

Authors:  A Paradiso; G Simone; S Petroni; B Leone; C Vallejo; J Lacava; A Romero; M Machiavelli; M De Lena; C J Allegra; P G Johnston
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

8.  Confirmation of double-peaked time distribution of mortality among Asian breast cancer patients in a population-based study.

Authors:  Fei Gao; Say Beng Tan; David Machin; Nan Soon Wong
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

9.  Hypertabastic survival model.

Authors:  Mohammad A Tabatabai; Zoran Bursac; David K Williams; Karan P Singh
Journal:  Theor Biol Med Model       Date:  2007-10-26       Impact factor: 2.432

10.  Time-varying pattern of postoperative recurrence risk of early-stage (T1a-T2bN0M0) non-small cell lung cancer (NSCLC): results of a single-center study of 994 Chinese patients.

Authors:  Jian-fei Zhu; Xing-yu Feng; Xue-wen Zhang; Ying-sheng Wen; Peng Lin; Tie-hua Rong; Ling Cai; Lan-jun Zhang
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.